Sonova Holding AG stock (CH0012549785): strong 2025/ 26 results, AI hearing push and higher profitability

Sonova Holding AG has reported solid results for its 2025/26 financial year, lifted profitability and outlined guidance for 2026/27, while pushing AI-enabled hearing solutions and a higher dividend. What stands behind the numbers – and why the stock matters for global investors.

Sonova Holding AG has released its results for the 2025/26 financial year, reporting mid-single-digit sales growth and a stronger increase in operating profit, while confirming guidance and highlighting continued market outperformance in hearing instruments and AI-enabled solutions, according to a company release dated May 18, 2026.Sonova investor news as of 05/18/2026 Group sales reached CHF 3,605.9 million, up 5.9% in local currencies, while normalized EBITA grew 17.3% to CHF 811.2 million, underlining improved profitability.

For the 2026/27 financial year, Sonova targets consolidated sales growth of 5–8% and core EBIT growth of 7–10% at constant exchange rates, signalling confidence in ongoing demand and operating leverage, as stated in the same May 18, 2026 release.Investing.com as of 05/18/2026 Management pointed to successful product launches and solid execution in the Hearing Instruments segment as key growth drivers.

As of: 18.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Sonova
• Sector/industry: Hearing care, medical technology
• Headquarters/country: Stäfa, Switzerland
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Hearing instruments, audiological services, cochlear implants
• Home exchange/listing venue: SIX Swiss Exchange (ticker: SOON)
• Trading currency: Swiss franc (CHF)

Sonova Holding AG: core business model

Sonova Holding AG is a global provider of hearing care solutions, with activities spanning the development, manufacturing and distribution of hearing instruments, cochlear implants and related audiological services. The company’s portfolio covers behind-the-ear and in-the-ear devices, custom earmolds, rechargeable systems and wireless accessories, as outlined in its 2025/26 annual report published in May 2026.Sonova Annual Report 2025/26 as of 05/2026 It serves both wholesale channels and company-owned retail networks under several brands.

The group reports in segments including Hearing Instruments and Cochlear Implants, with Hearing Instruments representing the majority of sales and profit. In the 2025/26 financial year, the Hearing Instruments segment delivered accelerated growth in the second half, driven by product launches and execution in wholesale and retail, according to the May 18, 2026 investor release.Sonova investor news as of 05/18/2026 This reflects Sonova’s strategy of combining technology innovation with direct consumer reach.

Sonova’s business model is built on capturing long-term structural demand trends such as aging populations, growing awareness of hearing health and wider access to audiological care. The company offers a broad range of price tiers and service models, allowing it to address public reimbursement markets as well as private-pay customers. In its 2025/26 report, Sonova emphasized sustained market share gains and operating leverage, suggesting that its scale and distribution depth are central to its competitive positioning.Sonova Annual Report 2025/26 as of 05/2026

Alongside hardware, Sonova increasingly integrates software, connectivity and digital services into its offerings. Wireless connectivity to smartphones, remote fitting options and cloud-based audiological tools are designed to improve the user experience and create recurring service revenue. The May 2026 reporting highlights that AI-enabled signal processing and personalized fitting algorithms are becoming more important in the company’s hearing instruments portfolio, which can support differentiation in crowded markets.TipRanks company announcement as of 05/18/2026

Main revenue and product drivers for Sonova Holding AG

In the 2025/26 financial year, Sonova generated group sales of CHF 3,605.9 million, representing 5.9% growth in local currencies, according to its May 18, 2026 earnings release.Sonova investor news as of 05/18/2026 Organic growth was 5.4%, with acquisitions, including the full-year contribution of previous deals, adding around 0.5 percentage points. This indicates that the bulk of expansion came from underlying demand rather than external consolidation.

Profitability increased more strongly than sales. Normalized EBITA in 2025/26 rose 17.3% in local currencies to CHF 811.2 million, reflecting operating leverage, a favorable product mix and cost discipline, as noted in the same release.Investing.com as of 05/18/2026 Despite currency headwinds, gross profit in local currencies increased 5.8% to CHF 2,658.3 million, with a gross margin of 73.7%, only slightly lower than in the prior year in constant currency terms.

The Hearing Instruments segment, combining wholesale distribution and the retail network, was a core growth driver. Sonova reported that growth in this segment accelerated in the second half of 2025/26 against a stronger comparison base, supported by successful product launches and solid field execution.Sonova investor news as of 05/18/2026 AI-enhanced devices and rechargeable platforms appear to have played a role in attracting new users and upgrades, according to coverage that described Sonova as beating the market with AI hearing solutions and achieving a record dividend.TipRanks company announcement as of 05/18/2026

From a geographic perspective, Europe, the Middle East and Africa (EMEA) remained an important revenue base, with sales in the region up 4.8% in local currencies in 2025/26, according to the May 18, 2026 release.Sonova investor news as of 05/18/2026 North America and Asia-Pacific are also significant markets, benefitting from demographic trends and rising penetration of hearing care products. The company noted some headwinds in China, but overall group profit still exceeded certain market expectations, highlighting resilience across regions.Investing.com as of 05/18/2026

For 2026/27, Sonova’s guidance for 5–8% sales growth and 7–10% core EBIT growth at constant exchange rates underscores management’s view that demand for hearing solutions remains structurally positive. The guidance takes into account ongoing investments in research and development, retail footprint and digital capabilities, as indicated in its investor communication dated May 18, 2026.Sonova financial reports overview as of 05/2026 The company’s outlook also assumes normalizing supply chains and continued adoption of premium and advanced technology devices.

Conclusion

Sonova Holding AG’s 2025/26 results show a combination of steady top-line expansion and stronger profit growth, supported by market share gains and a focus on higher-value products. The guidance for 2026/27 implies that management expects these trends to continue, though currency effects and regional headwinds such as China remain factors to monitor. For globally oriented investors, particularly those following healthcare and medical technology stocks on European exchanges, Sonova illustrates how demographic drivers and technology innovation can intersect in the hearing care segment without removing the usual risks of competition, pricing and macroeconomic uncertainty.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.